Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Apple (NASDAQ:AAPL) Enters Earnings Week With Record Revenue, a CEO Handover and an AI Reboot Still Unshipped

Apple (NASDAQ:AAPL) shares closed at $336.91, within a 52-week range of $201.50 to $339.57, for a market capitalisation near $4.95 trillion (data observed that period; prices and multiples change continuously). Press reports that day noted Apple had passed Nvidia to become the most valuable …

Nitish Kishor | 28 July 2026

Baiya International Group (NASDAQ:BIYA) Doubles Off a 52-Week Low as Filings Show a Second Reverse Split and a $200 Million Shelf

Baiya International Group Inc. (NASDAQ:BIYA) is a Cayman Islands exempted company whose Class A ordinary shares, ordinary equity, not a warrant, unit or preferred instrument, trade on the Nasdaq Capital Market. As a foreign private issuer it reports on Forms 20-F and 6-K, and …

Nitish Kishor | 28 July 2026

C3is (NASDAQ:CISS) Shares Fall About 70% in Days as $6 Million Warrant Offering Follows Two 2026 Reverse Splits

C3is Inc. (NASDAQ:CISS) is a ship-owning company incorporated in the Marshall Islands and managed from Kifissia, Athens. As a foreign private issuer it files Form 20-F annually and furnishes Form 6-K interim disclosures, not 10-Ks and 10-Qs.

Nitish Kishor | 28 July 2026

China SXT Pharmaceuticals (NASDAQ:SXTC) Loses 98% in Four Sessions as Volume Explodes and a $9 Million Raise Closes

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) is a British Virgin Islands-incorporated maker of traditional Chinese medicine pieces, based in Taizhou, Jiangsu province. Its Class A ordinary shares (not units, warrants or preferred stock) trade on the Nasdaq Capital Market under SXTC. As a foreign private …

Nitish Kishor | 28 July 2026

Entera Bio (NASDAQ:ENTX) Stock Jumps 91% as a $275 Million Private Placement Prices, Financing, Not Pipeline News, Drove the Move

Entera Bio Ltd. (NASDAQ:ENTX) is a clinical-stage biopharmaceutical company incorporated in Israel whose ordinary shares trade on the Nasdaq Capital Market as ENTX. It reports as a US domestic filer: EDGAR records under CIK 0001638097 show Forms 10-K, 10-Q and 8-K, not the 20-F …

Nitish Kishor | 28 July 2026

Gossamer Bio (NASDAQ:GOSS) Surges 47% as the FDA Opens an NDA Path for Seralutinib, But the Phase 3 Missed

Gossamer Bio, Inc. (NASDAQ:GOSS) is a San Diego-based, Delaware-incorporated clinical-stage biopharmaceutical company whose common stock trades on Nasdaq as GOSS. Its prospects rest almost entirely on seralutinib, an inhaled inhibitor of PDGFR, CSF1R and c-KIT for pulmonary arterial hypertension (PAH). Within five months it …

Nitish Kishor | 28 July 2026

Instinct Bio's (NASDAQ:BIOT) Nasdaq Listing Was a De-SPAC, Not an IPO, and BIOT Fell 76% in Its Second Session

Instinct Bio Technical Company Holdings Inc. (NASDAQ:BIOT) began trading, and by the close of the next session most of its market value was gone. It looked like a failed IPO. It was not one. BIOT reached Nasdaq through a SPAC deal in which nearly …

Nitish Kishor | 28 July 2026

KIDZ AI (NASDAQ:KIDZ) Stock Jumped 77% on a $44.6 Million GPU Contract, Then Round-Tripped as Its Share Count Doubled

KIDZ AI Inc. (NASDAQ:KIDZ) trades on the Nasdaq Capital Market under the ticker KIDZ. The listed security is Class B common stock, ordinary equity, not a unit, warrant, preferred share or fund. A separate warrant line, KIDZW, trades under its own symbol; a small …

Nitish Kishor | 28 July 2026

KLA (NASDAQ:KLAC) Reports Fiscal Q4 on July 28 With Shares a Third Below Their 52-Week High

KLA Corporation (NASDAQ:KLAC) supplies the inspection and metrology tools chipmakers use to find defects during manufacturing. Three things focus attention: Tuesday's fiscal year-end report, June's 10-for-1 split, and a sharp retreat from the highs. Market data providers put the close at $203.36, down 3.4% …

Nitish Kishor | 28 July 2026

AiRWA (NASDAQ:YYAI) Shares Fall 73.5% in One Session as a $50 Million Import-Export Deal Tests Its AI and Tokenization Story

AiRWA Inc. (NASDAQ:YYAI) is a Delaware corporation whose common stock trades on the Nasdaq Capital Market as YYAI, ordinary common stock, not a warrant or fund. It is not a foreign private issuer, filing domestic US reports (Forms 10-K, 10-Q and 8-K) under SEC …

Nitish Kishor | 28 July 2026
Support

Hi! How can we help you today?

Loading…